DM-1157 is an orally active asymmetric bisquinoline heme inhibitor with a IC 50 of 1.6 μM and a K d of 1.7 μM. DM-1157 binds to heme dimers in solution, inhibits β-hematin formation, suppresses hemozoin formation in the digestive vacuole of Plasmodium falciparum , accumulates in the digestive vacuole of Plasmodium falciparum , induces enlargement of the digestive vacuole of Plasmodium falciparum , and inhibits the growth of Chloroquine ( HY-17589A )-sensitive and resistant Plasmodium falciparum strains. DM-1157 can be used for the research of malaria and Plasmodium falciparum -type malaria.
Products | Products > Disease Areas > Infection | Products > Disease Areas > Parasitic Infection | Products > Disease Areas > Plasmodium Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Parasite
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.